Domestic and international life sciences companies, pharmaceutical manufacturers and retail companies, as well as medical institutions, turn to Djingov, Gouginski, Kyutchukov & Velichkov‘s pharma and healthcare practice group thanks to its broad advisory offering in this sector. Due to the firm’s full-service setup, the team is able to assist clients with matters ranging from day-to-day assistance, project-based legal assistance, commercial agreements, and representation in administrative and litigation proceedings, through to compliance advice on clinical trial agreements. Kalina Tchakarova heads up the practice and is well regarded for her expertise in the field of IP law, and experience advising pharmaceutical companies on medicinal products regulation.
Legal 500 Editorial commentary
Key clients
- Biogen Netherlands BV
- International SOS
- Swedish Orphan Biovitrum AB
- Novavax, Inc.
- Viatris (Mylan Ireland Limited and Mylan EOOD)
- Teva Pharmaceuticals Europe BV
- General Electric Healthcare
- Alnylam Pharmaceuticals, Inc
- Novo Nordisk A/S
- Organon Pharma (UK) Limited
Work highlights
- Advised Biogen Netherlands BV in a case regarding a leading medicinal product that had an expiring patent protection but was still protected against placement on the market of generic analogues.
- Assisted Swedish Orphan Biovitrum AB with various matters related to its market presence in Bulgaria.
- Advises Viatris in pending litigation related to the alleged infringement of the rights of Bayer HealthCare LLC to an EU patent in Bulgaria.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Practice head
The lawyer(s) leading their teams.
Kalina Tchakarova